Sites and functional consequence of VDAC–alkylphenol anesthetic interactions  by Weiser, Brian P. et al.
FEBS Letters 588 (2014) 4398–4403journal homepage: www.FEBSLetters .orgSites and functional consequence of VDAC–alkylphenol anesthetic
interactionshttp://dx.doi.org/10.1016/j.febslet.2014.10.009
0014-5793/ 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
⇑ Corresponding author at: 3620 Hamilton Walk, Philadelphia, PA 19104, United
States. Fax: +1 215 349 5078.
E-mail address: roderic.eckenhoff@uphs.upenn.edu (R.G. Eckenhoff).Brian P. Weiser a,b, Weiming Bu a, David Wong c, Roderic G. Eckenhoff a,⇑
aDepartment of Anesthesiology and Critical Care, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, United States
bDepartment of Pharmacology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, United States
cDrexel University College of Medicine, Philadelphia, PA 19129, United Statesa r t i c l e i n f o
Article history:
Received 14 August 2014
Revised 10 September 2014
Accepted 10 October 2014
Available online 18 October 2014





Photolabelinga b s t r a c t
General anesthetics have previously been shown to bind mitochondrial VDAC. Here, using a photo-
active analog of the anesthetic propofol, we determined that alkylphenol anesthetics bind to Gly56
and Val184 on rat VDAC1. By reconstituting rat VDAC into planar bilayers, we determined that pro-
pofol potentiates VDAC gating with asymmetry at the voltage polarities; in contrast, propofol does
not affect the conductance of open VDAC. Additional experiments showed that propofol also does
not affect gramicidin A properties that are sensitive to lipid bilayer mechanics. Together, this sug-
gests propofol affects VDAC function through direct protein binding, likely at the lipid-exposed
channel surface, and that gating can be modulated by ligand binding to the distal ends of VDAC
b-strands where Gly56 and Val184 are located.
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
The mitochondrial voltage-dependent anion channel (VDAC) is
a b-barrel protein in the mitochondrial outer membrane. Ions
and small metabolites diffuse through the open channel between
the cytosol and mitochondrial intermembrane space. The channel
remains open under low voltage and has twofold selectivity for
anions relative to cations. However, as the transmembrane poten-
tial increases to 30–40 mV, VDAC begins to change conformations
to various ‘‘closed’’ states. VDAC closure (also referred to as ‘‘gat-
ing’’) is characterized by a decrease in channel conductance and
a reversal in ion selectivity [1].
The functional properties of VDAC proteins are remarkably con-
served across eukaryotic species. However, VDAC function can be
affected by membrane composition [2,3], pH [4,5], speciﬁc pore
block [6], and the small molecule erastin [7]. A number of general
anesthetics have also been identiﬁed as VDAC ligands, with bind-
ing determined by photolabeling with anesthetic analogs [8–23].
These ligands bind VDAC from amphibians, insects, ﬁsh, and mam-
mals [8]. While these lipophilic compounds often bind integral
membrane proteins after partitioning into membranes, anestheticbinding to VDAC is generally saturable or speciﬁc [8]; however,
any direct functional relevance of anesthetic–VDAC binding has
not been identiﬁed.
In previous work, we determined that the anesthetic photolabel
meta-azi-propofol (AziPm), an analog of the clinically used com-
pound propofol (Fig. 1A), binds neuronal VDAC in vivo in Xenopus
laevis tadpoles [22]. We then determined that AziPm binding to
VDAC is inhibited by propofol, suggesting conserved binding of
the alkylphenols to some saturable VDAC site(s) [22]. To further
investigate alkylphenol–VDAC interactions, speciﬁcally the binding
sites and functional consequences, we transitioned our experi-
ments here to mammalian systems.
2. Materials and methods
2.1. Materials
Propofol (2,6-diisopropylphenol) was from Sigma–Aldrich, and
AziPm was synthesized according to published methods [24].
AziPm was tritiated by Ambios Labs (Newington, CT) and its appli-
cation has been reported previously [22]. Electrophoresis appara-
tuses and gels were from Bio-Rad, and DOPC and DOPE were
from Avanti Polar Lipids, Inc. (Alabaster, AL). Gramicidin A was a
generous gift of O.S. Andersen, Cornell University Medical College.
Instrumentation for scintillation counting and UV–Vis spectros-
copy are described elsewhere [22].
Fig. 1. (A) Propofol (top) and AziPm (bottom) (B) IEF/SDS–PAGE gel of rat brain mitochondria. Spots 1–5 primarily contain VDAC isoforms, and spot ‘‘m’’ contains malate
dehydrogenase 2. (C) The location of VDAC1 residues Gly56 and Val184, which are photolabeled by AziPm, are indicated in red spheres on the crystal structure of recombinant
rat VDAC. (Left), the protein surface is shown in mesh, and the view through the barrel is from the cytosolic side. (Right), the blue lines indicate the predicted hydrophobic–
hydrophilic interface of membrane lipids. Here, the cytosolic side is on the left.
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Female Sprague Dawley rats were anesthetized with isoﬂurane
before decapitation. The brains were homogenized in ice-cold iso-
lation buffer (0.32 M sucrose, 5 mM Tris, pH 7.4) supplemented
with protease inhibitors, and puriﬁed mitochondria were isolated
as described without detergents [25]. Aliquots of mitochondria
(>5 mg/ml) were frozen in isolation buffer until use.
2.3. IEF/SDS–PAGE
Mitochondria were pelleted, and after removing the isolation
buffer, pellets were washed twice with ice-cold 2 mM Tris, pH
7.4. After pelleting again, 150 lg of protein was dissolved in
125 ll of IEF/SDS–PAGE buffer (7 M urea, 2 M thiourea, 20 mM
DTT, 4% CHAPS, and 0.2% carrier ampholytes). Isoelectric focusing
and SDS–PAGE proceeded according to the manufacturer’s instruc-
tions using 7 cm IPG strips and 4–15% precast SDS–PAGE gels.
2.4. VDAC identiﬁcation and LC–MS/MS
Mitochondrial protein was separated by IEF/SDS–PAGE then
stained with Coomassie G-250. Protein spots that were candidates
for containing VDAC were identiﬁed based on molecular weight
and isoelectric point. These were excised for LC–MS/MS. Cysteines
were alkylated, and after trypsin digestion, samples were injected
into a nanoLC column with online electrospray into a Thermo LTQ
linear ion trap. XCalibur acquired raw data, and Sequest searched
b and y ions. For protein identiﬁcations, a database was down-
loaded from www.uniprot.org with the search term ‘‘rattus nor-
vegicus’’. Search parameters were 1 amu parent ion tolerance,
1 amu fragment ion tolerance, full tryptic digest, one missed cleav-age, variable methionine oxidation, and ﬁxed cysteine carboxyami-
domethylation. Filter parameters were Xcorr scores (+1 ion) 1.5, (+2
ion) 2.0, (+3 ion) 2.5, deltaCn 0.08, peptide probability >0.05, and
two unique peptides.
2.5. Mitochondria photolabeling
Mitochondria were diluted to 1 mg/ml in isolation buffer before
adding ligand(s). Samples were incubated at room temperature in
the dark for 10 min before photolabeling in a quartz cuvette (path-
length 1 mm) for 15 min with a lamp described elsewhere [22].
After photolabeling, mitochondria were pelleted and washed with
ice-cold isolation buffer, pelleted again, then washed twice with
2 mM Tris, pH 7.4. Subsequently, the pellet was dissolved in IEF/
SDS–PAGE buffer for two-dimensional electrophoresis.
2.6. Scintillation counting of VDAC spots
After IEF/SDS–PAGE of mitochondrial protein photolabeled with
[3H]AziPm, gels were Coomassie stained and scanned, and spot
intensity was quantiﬁed as previously described [22]. VDAC pro-
tein spots were then excised, dissolved in H2O2, and scintillation
counted. Scintillation counts were normalized to spot intensity
(i.e., protein abundance) for quantitative analyses.
2.7. Identiﬁcation of AziPm binding sites
Mitochondria photolabeled with AziPm were separated with
IEF/SDS–PAGE, the gels were stained, and protein spots were
excised and processed for LC–MS/MS as above after either trypsin
or chymotrypsin digestion. After LC–MS/MS, the spectra were
searched against rat sequences of VDAC1, VDAC2, VDAC3, and
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described above were used along with a maximum of three post-
translational modiﬁcations per peptide and a variable AziPm mod-
iﬁcation (+216.08 Da) on any residue. To sequence the N-terminus
of VDAC1, however, a speciﬁc search for alanine acetylation [26]
with partial tryptic digest was required. This procedure conﬁrmed
that the N-terminal methionine of VDAC1 is removed during pro-
tein maturation in vivo, and also that the second coded residue
(alanine) is acetylated [26]; however, we included the coded
methionine (Met1) in the numbering of amino acids. For protein
sequencing, only the highest scoring peptide assignment for each
spectrum was considered, and spectra of peptides containing
AziPm adducts were manually conﬁrmed.
2.8. Structural analyses
For structural analyses of rat VDAC1, we used PDB code 3EMN,
which represents a crystal structure of recombinant rat VDAC
refolded from inclusion bodies [27]. This was oriented in a hypo-
thetical membrane with the PPM server of Orientation of Proteins
in the Membrane [28], and PyMOL was used for generating struc-
tural images [29]. In addition to the 3EMN structure, we referenced
a proposed, alternatively-folded VDAC protein with a structural
topology that was deduced from experimental studies and has
been described elsewhere [30–32]. This protein is proposed to con-
tain an integral transmembrane helix and 13 b-strands [30–32];
however, a high-resolution structure of VDAC that is folded in this
manner is not available.
2.9. Reconstitution of VDAC into planar lipid bilayers
Frozen mitochondrial membranes from rat liver were kindly
provided by Marco Colombini (University of Maryland, College
Park). VDAC was isolated from the membranes by the standard
method [33] and puriﬁed on a 2:1 hydroxyapatite:celite column
following a previously described protocol [34]. Puriﬁed VDAC
was stored at 0.2 mg/ml in 10 mM Tris, pH 7.0, 50 mM KCl,
1 mM EDTA, 2.5% Triton X-100, and 15% DMSO at 80 C.
Planar lipid bilayers were formed from a lipid mixture of 1:1
DOPC:DOPE in pentane from two opposed preformed lipid mono-
layers as described previously [2,5]. Channel reconstitution was
achieved by adding 0.1–0.2 ll of puriﬁed VDAC to the 1.2 ml
aqueous solution of 1 M KCl buffered with 5 mM Hepes, pH 7.4,
in the cis compartment while stirring.
2.10. Electrophysiological recordings of VDAC
All electrophysiology experiments were performed essentially
as described [2,5]. Membrane potential was maintained by Ag/AgCl
electrodes with 3 M KCl and 15% agarose bridges. Potential was
deﬁned as positive when it is greater on the cis side, i.e. the side
of VDAC addition. An Axopatch 200B ampliﬁer (Axon Instruments,
Inc., Foster City, CA) was used in voltage clamp-mode. Single-chan-
nel currents were ﬁltered by the ampliﬁer low-pass Bessel ﬁlter at
10 kHz. Data were acquired with a Digidata 1440A board (Axon
Instruments, Inc.) at a sampling frequency of 50 kHz for single-
channel recordings, which were analyzed with pClamp 10.2 soft-
ware (Axon Instruments, Inc.).
For multichannel experiments, a symmetrical 5 mHz triangular
voltage wave with amplitude ±60 mV was applied with a Hewlett
Packard 33120A waveform generator [2,5], and data was saved
with a 1 Hz sampling frequency. Current responses to 5–10 periods
of triangular voltage waves were recorded. For subsequent analy-
ses, the parts of the wave in which VDAC re-opens (i.e., 60 mV
to +10 mV, and +60 to 10 mV) were used. Relative multichannelconductance and open probability plots were calculated based on
a previously described approach to gating analysis [2,5]. The gating
parameters V0 and n were calculated from the open probability
plots as extensively discussed elsewhere [2,5,35,36].
After collecting control data (0 lM propofol), both in single and
multichannel experiments, propofol diluted in 1 M KCl, 5 mM
Hepes, pH 7.4, was then added to the bath in both the trans and
cis compartments while stirring, and measurements were again
collected. After each experiment, the cis and trans aqueous solu-
tions were collected and the volumes were measured to determine
exact propofol concentrations, which were then conﬁrmed with
UV spectroscopy.
2.11. Gramicidin A experiments
Planar bilayers of 1:1 DOPC:DOPE were formed as described
above in 1 M KCl with 10 mM Hepes, pH 7.2. Gramicidin A from
109 M ethanol stock solution was added to both aqueous com-
partments at the amount sufﬁcient to give a single channel activity
(1 ll). For gramicidin A channel lifetime and conductance, the
records were digitally ﬁltered at 2 Hz using Bessel algorithm and
analyzed using Clampﬁt 10.2 software as described previously
[2]. After control recordings were obtained, propofol dissolved in
1 M KCl and 10 mM Hepes, pH 7.4, was added in increasing con-
centrations to both compartments. Mean channel conductance
was calculated from Gaussian ﬁts to current amplitude histograms,
and channel lifetimes were calculated from ﬁts to logarithmic sin-
gle exponents of at least 250 channel events [2].3. Results and discussion
To conﬁrm alkylphenol anesthetic binding to mammalian
VDAC, we ﬁrst enriched and identiﬁed VDAC protein. We puriﬁed
rat brain mitochondria then separated the protein with IEF/SDS–
PAGE. Initially guided by protein molecular weight and isoelectric
point, and subsequently conﬁrmed with LC–MS/MS, we identiﬁed
ﬁve spots that contained VDAC as the major component (Fig. 1B).
Although there are only three mammalian VDAC isoforms, each
can be post-translationally modiﬁed [37], which can alter protein
migration during isoelectric focusing. 64–91% of total spectra per
spot were assigned to VDAC (Table S1), and each spot contained
multiple isoforms.
With VDAC identiﬁed, we then photolabeled mitochondria with
10 lM [3H]AziPm ±100 lM propofol, again separated the protein
with IEF/SDS–PAGE, and dissolved the VDAC gel spots in H2O2.
Scintillation counting of the VDAC spots after [3H]AziPm photola-
beling revealed cpm signiﬁcantly above background (>4-fold each
spot), with no selectivity for any spot after normalizing for protein
mass. After conﬁrming that [3H]AziPm did not bind to the major
contaminant in the spots (malate dehydrogenase 2), we deter-
mined that 100 lM propofol decreased 10 lM [3H]AziPm binding
to VDAC by approximately 30%. This is in reasonable agreement
with the 50% displacement of 4 lM [3H]AziPm from X. laevis
VDAC by 400 lM propofol [22].
To identify alkylphenol site(s) on mammalian VDAC, we photo-
labeled mitochondria with 10 lM (non-radioactive) AziPm and
sequenced VDAC with LC–MS/MS. Residues photolabeled by AziPm
were identiﬁed by searching VDAC peptides for a 216 Da modiﬁca-
tion, which corresponds to the mass adduct of photo-reacted
AziPm [8]. With trypsin digest, we identiﬁed Gly56 on VDAC1 as
photolabeled in all ﬁve spots. To increase sequence coverage, we
also digested the most intense spot (spot 2) with chymotrypsin;
Val184 on VDAC1 and the homologous residue on VDAC2
(Val196) were identiﬁed as photolabeled (Figs. 1C, S1 and S2).
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the ﬁve spots, we sequenced 95.7% of VDAC1, 51.9% of VDAC2,
and 41.3% of VDAC3 (Fig. S1). Detection with LC–MS/MS is depen-
dent on protein abundance in the samples, which contributed to
the variability in sequence coverage, as relative spectra counts
for VDAC1:VDAC2:VDAC3 were approximately 10:3:1. Relative
abundance may have also contributed to the lack of identiﬁed
adducts on VDAC3 and a site on VDAC2. The photolabeled glycine
and valine of VDAC1 are conserved in all three isoforms, which
each share 70% sequence identity, and are believed to adopt iden-
tical folds [38–40]; therefore, alkylphenol binding to these residues
on all isoforms remains possible and perhaps likely.
To investigate the locations of the residues that alkylphenols
bind, we ﬁrst used the crystal structure of recombinant mouse
and rat VDAC1 (PDB code 3EMN) [27]. We oriented this VDAC
structure in a hypothetical membrane to calculate the hydrophobic
boundaries of the protein [28]. Both residues were on the cytosolic
half of the protein within the predicted bilayer [41], with Gly56
and Val184 at the periphery of b-strands 3 and 12, respectively.
The backbone a carbons of Gly56 and Val184 were 3.2 and 2.3 Å,
respectively, from the predicted hydrophobic–hydrophilic inter-
face of the protein (Fig. 1C). The membrane depths of these resi-
dues are consistent with the predicted distribution of propofol in
a bilayer, i.e. at the interface of lipid phospho-head groups and acyl
chains [42]. The topology of an alternatively-folded VDAC1 has also
been proposed [30–32], and interestingly, this model also placesFig. 2. (A) Current trace from a single VDAC channel reconstituted in a planar bilayer. N
gating was seen, and the open channel conductance in this experiment was 4.1 nS at eac
the maximum conductance for each experiment (Gmax), which occurs when all channels
channels in the membrane, which ranged between 8 and 22 per experiment. The mean
(17 lM propofol) experiments are shown (SD not shown for 17 lM). (Right), the mean G
with 2.8 and 8.6 lM propofol, respectively, compared to the control.Gly56 and Val184 at the hydrophobic–hydrophilic interface. How-
ever, in contrast to the crystal structure, the residues in this model
are placed near the membrane surface of opposite leaﬂets. Regard-
less, these binding sites should be readily accessible to free ligand
dissolved in lipid, assuming that propofol binds the VDAC residues
at the lipid-facing channel surface and not inside the pore.
After demonstrating conserved binding of the alkylphenol anes-
thetics to rat VDAC, we tested whether the clinical compound pro-
pofol affects its basic electrophysiological properties. For these
experiments, we used native VDAC isolated from rat liver mito-
chondria, which also contains a mixture of the three VDAC iso-
forms. We ﬁrst measured the conductance of open VDAC
reconstituted in a planar bilayer of 1:1 DOPC:DOPE (Fig. 2A). The
measured single channel conductance of 4 nS in a bath of 1 M
KCl, pH 7.4, is in agreement with previously published values [1].
Addition of propofol (1–18 lM) to the bath did not affect open
channel conductance, further suggesting that it is unlikely propofol
binds inside the open channel lumen (Figs. 2A, S3 and Table S2).
We therefore tested whether propofol affects the most charac-
teristic VDAC property, its voltage gating. For these experiments,
we used identical lipid and bath conditions as before, but reconsti-
tuted multiple channels into the planar membrane and applied a
slow symmetrical triangular voltage wave with amplitude
±60 mV [2,5,36,43]. At clinically relevant concentrations (1–
10 lM), propofol concentration-dependently promoted VDAC clo-
sure at negative voltages (Fig. 2B). Because VDAC inserts unidirec-egative and positive voltages were alternately applied as indicated. Typical VDAC
h voltage ± propofol. (B) (Left), VDAC conductance (G) at each voltage normalized to
are open at low voltage. Normalizing by Gmax accounts for the variable number of
s ± SD from four (control, 0 lM propofol), three (2.8 and 8.6 lM propofol), or two
/Gmax ± SE is shown for select voltages. At 45 mV, G/Gmax decreased by 8% and 17%
4402 B.P. Weiser et al. / FEBS Letters 588 (2014) 4398–4403tionally into these membranes [2], channel gating at positive and
negative voltages can be dissociated.
After VDAC closure, and in response to decreasing transmem-
brane voltage, re-opening of channels is fast (sub-milliseconds)
[44], and can be measured as an increase in channel conductance.
With a two-state model of VDAC gating, where the channel is
either open or closed, the conformational equilibrium of channel
re-opening can be quantitatively described by the gating parame-
ters V0, which is the voltage at which half the channels are open,
and n, which is the effective gating charge and describes the steep-
ness of the voltage dependence [2,36]. At negative voltage, propo-
fol did not affect either gating parameters V0 or n relative to control
experiments (Table S3), suggesting that propofol might speciﬁcally
inﬂuence initiation of VDAC gating as opposed to the dynamics
associated with channel re-opening.
A similar asymmetric increase in VDAC gating at the same (nega-
tive) voltage polarity has been previously observed by increasing the
mole fraction of non-lamellar lipids in themembrane [2,45]. This ini-
tially suggested that propofol might be affecting VDAC by changing
the properties of the surrounding membrane. However, in contrast
to propofol, membranes of non-lamellar lipids clearly affect channel
re-opening, as the voltage at which half the channels open, V0,
decreases while n remains constant [2]. Non-lamellar lipids likely
affect VDAC through increased lipid packing stress on the mem-
brane-embedded channel at the depth of lipid acyl chains. In the pro-
posedmodel [2], VDACconformational transitions are sensitive to the
pressure in the hydrophobic core of the lipid bilayer, and upon gating
at negative voltages, the external shape of the channel can relieve ele-
vated pressures that derive from that depth in the membrane [2,45].
Therefore, to further differentiate the effects of propofol from
those of non-lamellar lipids, we performed experiments with
gramicidin A, an ion channel with properties known to be modu-
lated by lipid bilayer mechanics. This channel is a sensitive molec-
ular probe of, e.g., lipid packing stress [2,46–48]. Gramicidin A
forms shorter-lived channels as the fraction of non-lamellar lipid
in the membrane increases [2,48]; however, propofol (1–40 lM)
did not affect gramicidin A channel lifetime or conductance in
DOPC/DOPE membranes (Fig. S4).
The absence of a propofol effect on gramicidin A suggests that
the general anesthetic acts directly on VDAC through protein bind-
ing, potentially through our identiﬁed sites. The measured effect of
propofol is enhanced VDAC closure at negative potentials. Together,
the locations of these sites suggest that the distal portions of b-
strands regulate the dynamics associated with initiating closure.
The physiological role of VDAC gating itself is a matter of conjecture
[49], and future work will aim to determine the relevance of
enhanced closure. Although it is unlikely that VDAC modulation
contributes to anesthetic hypnosis [12], potentiation of gating
could potentially modulate neuronal apoptosis or metabolism [49].Acknowledgements
We thank Tatiana Rostovtseva and Oscar Teijido for their excel-
lent guidance with VDAC electrophysiology techniques, and we
thank Michael Weinrich for performing the gramicidin A record-
ings. This work was partially supported by the Solomon and Cath-
erine Erulkar Traveling Fellowship awarded to B.P.W. Other
support was provided by the National Institutes of Health, includ-
ing through Grants F31-NS080519 and P01-GM055876.
Appendix A. Supplementary data
Supplementary data associated with this article can be found, in
the online version, at http://dx.doi.org/10.1016/j.febslet.2014.
10.009.References
[1] Colombini, M., Blachly-Dyson, E. and Forte, M. (1996) VDAC, a channel in the
outer mitochondrial membrane. Ion Channels 4, 169–202.
[2] Rostovtseva, T.K., Kazemi, N., Weinrich, M. and Bezrukov, S.M. (2006) Voltage
gating of VDAC is regulated by nonlamellar lipids of mitochondrial
membranes. J. Biol. Chem. 281, 37496–37506.
[3] Mlayeh, L., Chatkaew, S., Léonetti, M. and Homblé, F. (2010) Modulation of
plant mitochondrial VDAC by phytosterols. Biophys. J. 99, 2097–2106.
[4] Bowen, K.A., Tam, K. and Colombini, M. (1985) Evidence for titratable gating
charges controlling the voltage dependence of the outer mitochondrial
membrane channel, VDAC. J. Membr. Biol. 86, 51–59.
[5] Teijido, O., Rappaport, S.M., Chamberlin, A., Noskov, S.Y., Aguilella, V.M., et al.
(2014) Acidiﬁcation affects voltage-dependent anion channel functioning
asymmetrically: role of salt bridges. J. Biol. Chem. 289, 23670–23682.
[6] Gurnev, P.A., Rostovtseva, T.K. and Bezrukov, S.M. (2011) Tubulin-blocked
state of VDAC studied by polymer and ATP partitioning. FEBS Lett. 585, 2363–
2366.
[7] Bauer, A.J., Gieschler, S., Lemberg, K.M., McDermott, A.E. and Stockwell, B.R.
(2011) Functional model of metabolite gating by human voltage-dependent
anion channel 2. Biochemistry 50, 3408–3410.
[8] Weiser, B.P., Woll, K.A., Dailey, W.P. and Eckenhoff, R.G. (2014) Mechanisms
revealed through general anesthetic photolabeling. Curr. Anesthesiol. Rep. 4,
57–66.
[9] Xi, J., Liu, R., Asbury, G.R., Eckenhoff, M.F. and Eckenhoff, R.G. (2004)
Inhalational anesthetic-binding proteins in rat neuronal membranes. J. Biol.
Chem. 279, 19628–19633.
[10] Pan, J.Z., Xi, J., Tobias, J.W., Eckenhoff, M.F. and Eckenhoff, R.G. (2007)
Halothane binding proteome in human brain cortex. J. Proteome Res. 6, 582–
592.
[11] Darbandi-Tonkabon, R., Hastings, W.R., Zeng, C.-M., Akk, G., Manion, B.D., et al.
(2003) Photoafﬁnity labeling with a neuroactive steroid analogue. 6-Azi-
pregnanolone labels voltage-dependent anion channel-1 in rat brain. J. Biol.
Chem. 278, 13196–13206.
[12] Darbandi-Tonkabon, R., Manion, B.D., Hastings, W.R., Craigen, W.J., Akk, G.,
et al. (2004) Neuroactive steroid interactions with voltage-dependent anion
channels: lack of relationship to GABAA receptor modulation and anesthesia. J.
Pharmacol. Exp. Ther. 308, 502–511.
[13] Chen, Z.-W., Manion, B., Townsend, R.R., Reichert, D.E., Covey, D.F., et al. (2012)
Neurosteroid analog photolabeling of a site in the third transmembrane
domain of the b3 subunit of the GABA(A) receptor. Mol. Pharmacol. 82, 408–
419.
[14] Husain, S.S., Forman, S.A., Kloczewiak, M.A., Addona, G.H., Olsen, R.W., et al.
(1999) Synthesis and properties of 3-(2-hydroxyethyl)-3-n-pentyldiazirine, a
photoactivable general anesthetic. J. Med. Chem. 42, 3300–3307.
[15] Pratt, M.B., Husain, S.S., Miller, K.W. and Cohen, J.B. (2000) Identiﬁcation of
sites of incorporation in the nicotinic acetylcholine receptor of a
photoactivatible general anesthetic. J. Biol. Chem. 275, 29441–29451.
[16] Husain, S.S., Ziebell, M.R., Ruesch, D., Hong, F., Arevalo, E., et al. (2003) 2-(3-
Methyl-3H-diaziren-3-yl)ethyl 1-(1-phenylethyl)-1H-imidazole-5-
carboxylate: a derivative of the stereoselective general anesthetic etomidate
for photolabeling ligand-gated ion channels. J. Med. Chem. 46, 1257–1265.
[17] Husain, S.S., Nirthanan, S., Ruesch, D., Solt, K., Cheng, Q., et al. (2006) Synthesis
of triﬂuoromethylaryl diazirine and benzophenone derivatives of etomidate
that are potent general anesthetics and effective photolabels for probing sites
on ligand-gated ion channels. J. Med. Chem. 49, 4818–4825.
[18] Husain, S.S., Stewart, D., Desai, R., Hamouda, A.K., Li, S.G.-D., et al. (2010) p-
Triﬂuoromethyldiazirinyl-etomidate: a potent photoreactive general
anesthetic derivative of etomidate that is selective for ligand-gated cationic
ion channels. J. Med. Chem. 53, 6432–6444.
[19] Ziebell, M.R., Nirthanan, S., Husain, S.S., Miller, K.W. and Cohen, J.B. (2004)
Identiﬁcation of binding sites in the nicotinic acetylcholine receptor for
[3H]azietomidate, a photoactivatable general anesthetic. J. Biol. Chem. 279,
17640–17649.
[20] Hamouda, A.K., Stewart, D.S., Husain, S.S. and Cohen, J.B. (2011) Multiple
transmembrane binding sites for p-triﬂuoromethyldiazirinyl-etomidate, a
photoreactive Torpedo nicotinic acetylcholine receptor allosteric inhibitor. J.
Biol. Chem. 286, 20466–20477.
[21] Emerson, D.J., Weiser, B.P., Psonis, J., Liao, Z., Taratula, O., et al. (2013) Direct
modulation of microtubule stability contributes to anthracene general
anesthesia. J. Am. Chem. Soc. 135, 5389–5398.
[22] Weiser, B.P., Kelz, M.B. and Eckenhoff, R.G. (2013) In vivo activation of
azipropofol prolongs anesthesia and reveals synaptic targets. J. Biol. Chem.
288, 1279–1285.
[23] Stewart, D.S., Savechenkov, P.Y., Dostalova, Z., Chiara, D.C., Ge, R., et al. (2011)
P-(4-Azipentyl)propofol: a potent photoreactive general anesthetic derivative
of propofol. J. Med. Chem. 54, 8124–8135.
[24] Hall, M.A., Xi, J., Lor, C., Dai, S., Pearce, R., et al. (2010) M-Azipropofol (AziPm) a
photoactive analogue of the intravenous general anesthetic propofol. J. Med.
Chem. 53, 5667–5675.
[25] Sims, N.R. and Anderson, M.F. (2008) Isolation of mitochondria from rat brain
using Percoll density gradient centrifugation. Nat. Protoc. 3, 1228–1239.
[26] Kayser, H., Kratzin, H.D., Thinnes, F.P., Götz, H., Schmidt, W.E., et al. (1989)
Identiﬁcation of human porins. II. Characterization and primary structure of a
B.P. Weiser et al. / FEBS Letters 588 (2014) 4398–4403 440331-lDa porin from human B lymphocytes (Porin 31HL). Biol. Chem. Hoppe
Seyler 370, 1265–1278.
[27] Ujwal, R., Cascio, D., Colletier, J.-P., Faham, S., Zhang, J., et al. (2008) The crystal
structure of mouse VDAC1 at 2.3 A resolution reveals mechanistic insights into
metabolite gating. Proc. Natl. Acad. Sci. U.S.A. 105, 17742–17747.
[28] Lomize, M.A., Pogozheva, I.D., Joo, H., Mosberg, H.I. and Lomize, A.L. (2012)
OPM database and PPM web server: resources for positioning of proteins in
membranes. Nucleic Acids Res. 40, D370–D376.
[29] The PyMOL Molecular Graphics System, Version 1.5.0.4, Schrödinger LLC.
[30] Song, J., Midson, C., Blachly-Dyson, E., Forte, M. and Colombini, M. (1998) The
topology of VDAC as probed by biotin modiﬁcation. J. Biol. Chem. 273, 24406–
24413.
[31] Colombini, M. (2004) VDAC: the channel at the interface between
mitochondria and the cytosol. Mol. Cell. Biochem. 256–257, 107–115.
[32] Colombini, M. (2009) The published 3D structure of the VDAC channel: native
or not? Trends Biochem. Sci. 34, 382–389.
[33] Blachly-Dyson, E., Peng, S., Colombini, M. and Forte, M. (1990) Selectivity
changes in site-directed mutants of the VDAC ion channel: structural
implications. Science 247, 1233–1236.
[34] Palmieri, F. and De Pinto, V. (1989) Puriﬁcation and properties of the voltage-
dependent anion channel of the outer mitochondrial membrane. J. Bioenerg.
Biomembr. 21, 417–425.
[35] Colombini, M. (1989) Voltage gating in the mitochondrial channel, VDAC. J.
Membr. Biol. 111, 103–111.
[36] Thomas, L., Blachly-Dyson, E., Colombini, M. and Forte, M. (1993) Mapping of
residues forming the voltage sensor of the voltage-dependent anion-selective
channel. Proc. Natl. Acad. Sci. U.S.A. 90, 5446–5449.
[37] Kerner, J., Lee, K., Tandler, B. and Hoppel, C.L. (2012) VDAC proteomics: post-
translation modiﬁcations. Biochim. Biophys. Acta BBA Biomembr. 1818, 1520–
1525.
[38] Komarov, A.G., Deng, D., Craigen, W.J. and Colombini, M. (2005) New insights
into the mechanism of permeation through large channels. Biophys. J. 89,
3950–3959.
[39] Schredelseker, J., Paz, A., López, C.J., Altenbach, C., Leung, C.S., et al. (2014) High
resolution structure and double electron-electron resonance of the zebraﬁshvoltage-dependent anion channel 2 reveal an oligomeric population. J. Biol.
Chem. 289, 12566–12577.
[40] Amodeo, G.F., Scorciapino, M.A., Messina, A., De Pinto, V. and Ceccarelli, M.
(2014) Charged residues distribution modulates selectivity of the open state of
human isoforms of the voltage dependent anion-selective channel. PLoS One
9, e103879.
[41] Tomasello, M.F., Guarino, F., Reina, S., Messina, A. and De Pinto, V. (2013) The
voltage-dependent anion selective channel 1 (VDAC1) topography in the
mitochondrial outer membrane as detected in intact cell. PLoS One 8, e81522.
[42] Hansen, A.H., Sørensen, K.T., Mathieu, R., Serer, A., Duelund, L., et al. (2013)
Propofol modulates the lipid phase transition and localizes near the
headgroup of membranes. Chem. Phys. Lipids 175–176, 84–91.
[43] Vander Heiden, M.G., Chandel, N.S., Li, X.X., Schumacker, P.T., Colombini, M.,
et al. (2000) Outer mitochondrial membrane permeability can regulate
coupled respiration and cell survival. Proc. Natl. Acad. Sci. U.S.A. 97, 4666–
4671.
[44] Colombini, M. (1979) A candidate for the permeability pathway of the outer
mitochondrial membrane. Nature 279, 643–645.
[45] Rostovtseva, T.K. and Bezrukov, S.M. (2008) VDAC regulation: role of
cytosolic proteins and mitochondrial lipids. J. Bioenerg. Biomembr. 40,
163–170.
[46] Lundbaek, J.A. and Andersen, O.S. (1999) Spring constants for channel-induced
lipid bilayer deformations. Estimates using gramicidin channels. Biophys. J.
76, 889–895.
[47] Suchyna, T.M., Tape, S.E., Koeppe, R.E., Andersen, O.S., Sachs, F., et al. (2004)
Bilayer-dependent inhibition of mechanosensitive channels by neuroactive
peptide enantiomers. Nature 430, 235–240.
[48] Weinrich, M., Rostovtseva, T.K. and Bezrukov, S.M. (2009) Lipid-dependent
effects of halothane on gramicidin channel kinetics: a new role for lipid
packing stress. Biochemistry 48, 5501–5503.
[49] Lemasters, J.J. and Holmuhamedov, E. (2006) Voltage-dependent anion
channel (VDAC) as mitochondrial governator—thinking outside the box.
Biochim. Biophys. Acta BBA Mol. Basis Dis. 1762, 181–190.
